Mayland, Catriona R.
Collinson, Michelle
Ahmedzai, Sam H.
Lucas, Joseph
Gath, Jacqui
Darlison, Liz
Defonseka, Duneesha
Laird, Barry
Stanley, Helena
Danson, Sarah
Gardiner, Clare
Bibby, Anna C.
,
Bibby, Anna
Rahman, Najib
Pugh, Bethan
Darlison, Liz
Walters, James
Fallon, Janet
Corcoran, John P
Dixon, Mairead
Slaven, Kate
Aujayeb, Avinash
Brown, Louise
Beckett, Paul
Blyth, Kevin
Tsim, Selina
Maclay, John
Cox, Giles
Shaw, Paul
Chamberlin, Naomi
Lawson, Malcolm
Mukherjee, Dipak
Dancey, Gairin
Islam, Rafiqul
de Fonseka, Duneesha
Mishra, Eleanor
Sage, Beth
Barr, Charlotte
Pope, Tony
Guglani, Sam
Yousif, Saif
Stanton, Andrew
Day, Helen
Morley, Anna
James, Kerra
Patole, Sonia
Azubuike-Dyer, Emeka
Tucker, Emma
Symonds, Jenny
Maskell, Nick
Bhatnagar, Rahul
Walker, Steven
Arnold, David
Clive, Amelia
Lynch, Geraldine A
Sadler-Ladell, Jasmin
Panduro, Tine
Redwood, Dawn
Wainwright, Tania
Tilley, Joanna
Jones, Christine
Mills, Matthew
Holt, Lyndsey
Jackson, Karl
Dismore, Lorell
Taylor, Leah
Wallace, Helen
Korley, Mercy
Ibatuliniene, Zita
Macpherson, Alexandra
Hughes, Stephanie
O’Hare, Megan
Dunne, Charlene
Flynn, Margaret
Smith, Susan
Jones, Laurie
Elkaram, Nadia
Nichols, Lesley
Shea, Debbie
Goodsell, Kerry
Hudig, Lisa
Roberson, Anna
Addison, Anglise
Begum, Masuma
Bagshaw, Melissa
Thatcher, Hilary
Cotter, Sarah
McRoberts, Kate
Funding for this research was provided by:
Asthma and Lung UK (APP11-1)
Article History
Received: 9 July 2025
Accepted: 3 June 2026
First Online: 13 June 2026
Declarations
Ethics approval and consent to participate: Approval for the ASSESS-meso study was obtained from the Research Ethics Committee Southwest – Central Bristol (17-SW-0019) and Health Research Authority (IRAS ID 220360). An ethical amendment was approved to commence the sub-study on 8th December 2020. Our study adhered to the principles of the Declaration of Helsinki. Informed consent was obtained from all participants.
Consent for publication: Not applicable.
Competing Interests: CRM has received research funding from Asthma and Lung UK, NIHR and Yorkshire Cancer Research. MC has received research funding from Asthma and Lung UK. SHA has received personal honorarium from Mundipharma and Grunenthal for lectures and presentations at educational events. BL has received consulting fees from Artelo, Nutricia, Actimed and personal honorarium from Abbott for lectures and presentations at educational events. CG has received grant funding from Mesothelioma UK for the establishment of the Mesothelioma UK Research Centre 2020–2025. AB has received research funding from Asthma and Lung UK, NIHR, Avon Mesothelioma Foundation, Cancer Research UK, and Fujirebio. JL, JG, LD, DD, and HS have no conflicts of interest.